XML 38 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
TDCC Consolidated Statements of Equity Statement - USD ($)
$ in Millions
Total
Common Stock
Add'l Paid-in Capital
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP
Treasury Stock [Member]
The Dow Chemical Company
The Dow Chemical Company
Common Stock
The Dow Chemical Company
Add'l Paid-in Capital
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Unearned ESOP
The Dow Chemical Company
Treasury Stock [Member]
Dow Inc. [Member]
The Dow Chemical Company
Add'l Paid-in Capital
Dow Inc. [Member]
The Dow Chemical Company
Retained Earnings [Member]
DowDuPont
The Dow Chemical Company
Add'l Paid-in Capital
DowDuPont
The Dow Chemical Company
Retained Earnings [Member]
Beginning balance at Dec. 31, 2016   $ 3,107 $ 4,262 $ 30,338 $ (9,822) $ (239) $ (1,659)   $ 3,107 $ 4,262 $ 30,338 $ (9,822) $ (239) $ (1,659)        
Merger impact   3,107 2,172       935   (3,107) 2,172       935        
Common stock issued/sold     423       724     423       724        
Issuance of parent company stock     66                       $ 0   $ 66  
Stock-based compensation and allocation of ESOP shares     (368)     50       (368)     50          
Other     2 25           (2) (25)              
Adoption of accounting standards (Note 1)       0 0           0 0            
Net income (loss) available for The Dow Chemical Company common stockholder $ 465     465       $ 465     465              
Dividends to stockholders       (1,673)             (1,673)              
Dividends to parent       (1,056)                       $ 0   $ (1,056)
Settlements and transfers related to separation from DowDuPont Inc. (6)     5,693 0     (6)     5,693              
Other comprehensive income (loss) 1,231       1,231     1,231       1,231            
ESOP shares acquired           0             0          
Ending balance at Dec. 31, 2017 32,701 0 6,553 33,742 (8,591) (189) 0 32,701 0 6,553 33,742 (8,591) (189) 0        
The Dow Chemical Company’s stockholder's equity 31,515             31,515                    
Noncontrolling interests 1,186             1,186                    
Merger impact   0 0       0   0 0       0        
Common stock issued/sold     0       0     0       0        
Issuance of parent company stock     112                       0   112  
Stock-based compensation and allocation of ESOP shares     377     55       377     55          
Other     0 19           0 (19)              
Adoption of accounting standards (Note 1)       989 (1,037)           989 (1,037)            
Net income (loss) available for The Dow Chemical Company common stockholder 4,641     4,641       4,641     4,641              
Dividends to stockholders       0             0              
Dividends to parent       (3,711)                       0   (3,711)
Settlements and transfers related to separation from DowDuPont Inc. 240     (182) 0     240     (182)              
Other comprehensive income (loss) (257)       (257)     (257)       (257)            
ESOP shares acquired           0             0          
Ending balance at Dec. 31, 2018 33,621 0 7,042 35,460 (9,885) (134) 0 33,621 0 7,042 35,460 (9,885) (134) 0        
The Dow Chemical Company’s stockholder's equity 32,483             32,483                    
Noncontrolling interests 1,138             1,138                    
Merger impact   0 0       0   0 0       0        
Common stock issued/sold     57       0     0       0        
Issuance of parent company stock     28                       $ 65   $ 28  
Stock-based compensation and allocation of ESOP shares     235     45       235     45          
Other     37 14           (37) (14)              
Adoption of accounting standards (Note 1)       (151) 0           (151) 0            
Net income (loss) available for The Dow Chemical Company common stockholder (1,359)     (1,359)       (1,237)     (1,237)              
Dividends to stockholders       (1,550)             0              
Dividends to parent       (535)                       $ (201)   $ (535)
Settlements and transfers related to separation from DowDuPont Inc. (1,935)     (14,806) 793     61     (16,009) 793            
Other comprehensive income (loss) (1,154)       (1,154)     (1,154)       (1,154)            
ESOP shares acquired           (2)             (2)          
Ending balance at Dec. 31, 2019 14,094 $ 8 $ 7,325 $ 17,045 $ (10,246) $ (91) $ (500) 14,862 $ 0 $ 7,333 $ 17,313 $ (10,246) $ (91) $ 0        
The Dow Chemical Company’s stockholder's equity 13,541             14,309                    
Noncontrolling interests $ 553             $ 553